Ultragenyx Bets For GeneTx On GTX-102 Drug For Angelman Syndrome
According to the biopharmaceutical company Ultragenyx, they have been working on a new drug termed ‘GTX-102’ that can potentially cure Angelman syndrome. Ultragenyx had started the research and medical tests into the drug back in 2021 when it had decided to acquire another company Genex. How Was The Test Conducted, And Why Was It Paused?…